UPC Analytics
ENDE
Overview · Filed: Jul 3, 2025

UPC_CFI_620/2025

LIPOSOMES WITH LIPIDS HAVING AN ADVANTAGEOUS PKA-VALUE FOR RNA DELIVERY

InfringementMain Infringement ActionThe Hague LDInfringementWritten Phase
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • GlaxoSmithKline Biologicals SA
Reps: Carlos Andres van Staveren (Bird & Bird); Tjibbe Douma (Bird & Bird); Nicole Jadeja (Bird & Bird)

Respondents

  • C.P. Pharmaceuticals International C.V.
  • Pfizer Export B.V.
  • Pfizer B.V.
  • Pfizer Manufacturing Belgium NV
  • Pfizer Service Company B.V./S.r.l.
  • Pfizer S.A./N.V.
  • Pfizer Luxembourg S.a.r.l.
  • Pfizer, Inc.
  • Pfizer Corporation Austria Gesellschaft m.b.H
  • Pfizer Aps
  • Pfizer Oy
  • Pfizer SAS
  • Pfizer Pharma GmbH
  • Pfizer S.r.l.
  • Laboratórios Pfizer, Lda.
  • Pfizer Romania S.R.L.
  • Pfizer AB
  • Pfizer, spol. S.r.o.
  • Pfizer Hellas A.E.
  • Pfizer, S.L.
  • Pfizer Croatia d.o.o.
  • Pfizer Gyógyszerkereskedelmi Kft.
  • Pfizer Polska Sp. Z.o.o.
  • Pfizer Trading Polska Sp. Z.o.o.
  • Pfizer AG
  • Pfizer AS
  • BioNTech SE
  • BioNTech Europe GmbH
  • BioNTech Manufacturing GmbH
  • BioNTech Manufacturing Marburg GmbH
Judges
  • Edger Brinkman
  • Margot Kokke
  • Stefan Schilling
  • Martin Schmidt
Patents
  • EP2590626
CPC codes: A61K31/7088, A61K9/127, A61K39/39, A61P31/04, A61P35/00, C12N2760/18534, C12N2770/36134, Y02A50/30, A61K39/12, A61P31/12, A61P31/10, A61K2039/53…

Technology area: Biotech · mRNA Vaccine

Sector: Biotechnology

Outcome
Procedural onlyProcedural only (no substantive ruling yet)
Filed: Jul 3, 2025
First decided: Feb 25, 2026
Language: English
Open on UPC Registry